Sometimes, the market gives up on a company. Investors become so disillusioned that they assume past difficulties will persist indefinitely. This appears to be the fate of PZ Cussons (LSE: PZC), a once-strong consumer-goods business that has faced multiple headwinds in recent years. Its share price is down by more than 75% in the last ten years and it has a valuation that suggests the market sees its struggles as the new normal. But is this truly the case, or does the stock now present an attractive contrarian opportunity?
PZ Cussons owns a range of personal-care, beauty and home-care brands. Its portfolio includes brands such as Carex, Imperial Leather and St. Tropez. These are repeat-buy, fast-moving consumer goods and are usually considered by investors to be dependable. Yet, despite the apparently defensive business, the company has suffered from a combination of external pressures and internal missteps that have weighed heavily on its performance.
The firm’s share price peaked in 2014. Arguably, at that time, the shares were too expensive and consequently declined modestly over the next five years. Since 2019, however, bigger problems have started to emerge. A major source of difficulty has been its exposure to Nigeria, which historically is an important market for the business – it started over 140 years ago as a trading company in the region. Currency devaluations, economic instability and high inflation have battered PZ Cussons’ operations in the region, eroding profitability and creating unpredictability in financial performance.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Nigeria remains a large part of the business today, making up roughly a quarter of the business, and its struggles there have become a major source of difficulty within the company. The devaluation of the Nigerian currency (naira) in 2023 was a particularly painful blow, forcing PZ Cussons to take large foreign-exchange-related hits to earnings. Compounding this, weaker consumer confidence and supply-chain disruptions have made it harder to pass on cost increases to customers.
Aside from Nigeria, PZ Cussons has also faced more universal pressures. The inflationary environment has led to higher costs across its supply chain, while intense competition in its key divisions has limited its ability to raise prices without losing market share. At the same time, its UK operations have struggled with declining demand in some of its core product segments.
Recent years have, then, been tough, but PZ Cussons is not standing still. The management team, led by CEO Jonathan Myers since 2020, has been taking decisive steps to stabilise and revitalise the business. The company’s turnaround plan focuses on three key areas: brand strengthening, portfolio simplification, and cost efficiencies.
First, PZ Cussons has been refocusing on its core brands. Rather than spreading itself too thinly across a broad portfolio, it is doubling down on its strongest assets. This includes investing in marketing and innovation for flagship products such as Carex and St. Tropez, aiming to drive greater consumer loyalty and pricing power. The firm has already seen encouraging signs, with its beauty segment performing well in developed markets.
Second, management is streamlining operations by divesting non-core brands and markets. This is particularly important given the complexity and volatility associated with its Nigerian business. While Nigeria remains a strategic market, PZ Cussons is working to de-risk its exposure and reduce dependence on its historically volatile contributions to group profits. The recent sale of its Polish and Greek businesses is part of this broader rationalisation strategy.
Third, the company is implementing cost-saving initiatives to enhance efficiency. This includes optimising its supply chain, reducing overheads and improving operational execution. These efforts are particularly important in mitigating inflationary pressures and protecting profit margins.
Can PZ Cussons prove the doubters wrong?
The big question for investors is whether these efforts will be enough to return PZ Cussons to sustainable growth. Earnings are at a low ebb, and the company’s shares currently trade on a price/ earnings (p/e) ratio of around ten, which suggests the market remains sceptical. However, this valuation looks attractive if the turnaround strategy proves successful – if, in particular, PZ Cussons can navigate its Nigerian challenges more effectively. At the same time, a stronger performance from its premium beauty brands could provide a much-needed boost to group profitability, as these typically carry higher margins.
History suggests that consumer goods companies with strong brands and disciplined management can recover from difficult periods. PZ Cussons is not a broken business, rather, it is a company that has faced significant but surmountable hurdles. If management can deliver on its strategy, then today’s depressed share price may ultimately prove to be a compelling entry point.
As always, there are risks. Nigeria remains a complex market and macroeconomic headwinds could persist longer than expected. However, the company’s underlying brands still hold significant value, and its cost-cutting initiatives should provide resilience even in a tough environment.
The stock market is littered with firms that were once written off but later proved doubters wrong. PZ Cussons has work to do, but if it can execute its recovery plan, then the market’s current pessimism may turn out to be misplaced. For brave investors, this could be an opportunity to buy a recovering consumer goods company at an undemanding valuation. This is one to watch. Any signs of a return to the good times are to be taken as a buying opportunity.
This article was first published in MoneyWeek's magazine. Enjoy exclusive early access to news, opinion and analysis from our team of financial experts with a MoneyWeek subscription.
-
Inheritance tax receipts surge by 10% – can you reduce your IHT liabilities?Bereaved families are paying more than ever in inheritance tax, but there are some ways to reduce your bill.
-
Premium Bonds hotspots: The UK counties with the best chances of winningMillions of people across the UK hold money in Premium Bonds, but are you more likely to win if you live in a certain part of the country?
-
Out of America's shadow: Why Trump's tariff chaos may be good for non-US stocksOpinion Upending global investment and trade could benefit other countries at the expense of the US market, says Cris Sholto Heaton
-
LendInvest: a promising fintech firm going cheapOpinion LendInvest has made some mistakes in the past, but it’s now primed for growth, says Rupert Hargreaves
-
BP's 'long, painful decline' – and why next year could be even tougherOpinion Long-suffering shareholders in oil giant BP have been pushing for change. It won’t come soon enough, says Matthew Lynn
-
Investment trusts tap the profits in exotic and obscure global marketsOpinion Peter Walls, manager of the Unicorn Mastertrust fund, highlights three investment trusts as he shares where he'd put his money
-
The star small and mid-cap stocks income investors have overlookedOpinion Thomas Moore, senior investment director, Aberdeen, highlights three company stocks as he shares where he would put his money
-
Falling revenues and mounting debt spell trouble for Jumia TechnologiesStruggling African e-commerce platform Jumia Technologies looks headed for the exit, says Dr Matthew Partridge.
-
Chemring Group: an explosive investment opportunity in defenceEuropean states are raising their military spending, and Chemring Group looks well placed to profit
-
Next reports £1 billion in annual profits for the first time – what's next for the retailer?Clothing retailer Next has become only the fourth member of its sector to surpass £1 billion in annual profits. What does this mean for the company's future?
